You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 92 No. 4, October 1965 TABLE OF CONTENTS
  Archives
  •  Online Features
  SPECIAL ARTICLE
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (2)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Early and Latent Syphilis

Current Management

PHILIP M. CATALANO, MD; ALAN H. SCHRAGGER, MD

Arch Dermatol. 1965;92(4):433-435.


Abstract

A total of 4.8 million units of benzathine penicillin G, divided into two doses one week apart, is recommended for the treatment of primary, secondary, and latent syphilis. No spinal tap is required in primary or secondary syphilis, in contrast to latent syphilis. The modified "triple-test plan" is used for the separation of the biologic false-positive (BFP) from the syphilitic serologic reactions.



Author Affiliations

MIAMI; BALTIMORE

From the Department of Dermatology, University of Miami School of Medicine, Miami, Florida. Dr. Schragger is currently with the Division of Dermatology, Johns Hopkins School of Medicine, Baltimore.


Footnotes

Accepted for publication May 12, 1965.

Reprint requests to 1600 NW 10th Ave, Miami, Fla 33136 (Dr. Catalano).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Systemic Antibiotics for Treatment of Acne Vulgaris: Efficacy and Safety
Arch Dermatol 1975;111:1630-1636.
ABSTRACT  

Dose-Related Seroreversal in Syphilis
Durst et al.
Arch Dermatol 1973;108:663-664.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1965 American Medical Association. All Rights Reserved.